Cooper/Haims Advisors, LLC Ampio Pharmaceuticals, Inc. Transaction History

Cooper/Haims Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 04, 2021	SELL	$1.56 - $1.98 $15,600 - $19,800	-10,000 Closed	0 $0
Q1 2021 Apr 28, 2021	BUY	$1.36 - $2.49 $13,600 - $24,900	10,000 New	10,000 $17,000
Q3 2020 Nov 05, 2020	SELL	$0.61 - $1.17 $7,930 - $15,209	-13,000 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$0.47 - $0.72 $6,110 - $9,360	13,000 New	13,000 $8,000

96.6K

Ticker AMPE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,287,008
Description
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...

Get notified when there are updates to the investment portfolio of Cooper/Haims Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Cooper/Haims Advisors, LLC with notifications on news.